Show simple item record

dc.contributor.authorSiddharta, Anindya
dc.contributor.authorPfaender, Stephanie
dc.contributor.authorVielle, Nathalie Jane
dc.contributor.authorDijkman, Ronald
dc.contributor.authorFriesland, Martina
dc.contributor.authorBecker, Britta
dc.contributor.authorYang, Jaewon
dc.contributor.authorEngelmann, Michael
dc.contributor.authorTodt, Daniel
dc.contributor.authorWindisch, Marc P
dc.contributor.authorBrill, Florian H
dc.contributor.authorSteinmann, Joerg
dc.contributor.authorSteinmann, Jochen
dc.contributor.authorBecker, Stephan
dc.contributor.authorAlves, Marco P
dc.contributor.authorPietschmann, Thomas
dc.contributor.authorEickmann, Markus
dc.contributor.authorThiel, Volker
dc.contributor.authorSteinmann, Eike
dc.date.accessioned2017-06-22T09:40:09Z
dc.date.available2017-06-22T09:40:09Z
dc.date.issued2017-03-15
dc.identifier.citationVirucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses. 2017, 215 (6):902-906 J. Infect. Dis.en
dc.identifier.issn1537-6613
dc.identifier.pmid28453839
dc.identifier.doi10.1093/infdis/jix046
dc.identifier.urihttp://hdl.handle.net/10033/620973
dc.description.abstractThe World Health Organization (WHO) published 2 alcohol-based formulations to be used in healthcare settings and for outbreak-associated infections, but inactivation efficacies of these products have not been determined against (re-)emerging viruses. In this study, we evaluated the virucidal activity of these WHO products in a comparative analysis. Zika virus (ZIKV), Ebola virus (EBOV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) as (re-)emerging viral pathogens and other enveloped viruses could be efficiently inactivated by both WHO formulations, implicating their use in healthcare systems and viral outbreak situations.
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleVirucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.en
dc.typeArticleen
dc.contributor.departmentTWINCORE, Zentrum für experimentelle und klinische Infektionsforschung gmbH, Feodor-Lynen Str. 7, 30625 Hannover, Germany.en
dc.identifier.journalThe Journal of infectious diseasesen
refterms.dateFOA2018-06-12T16:52:37Z
html.description.abstractThe World Health Organization (WHO) published 2 alcohol-based formulations to be used in healthcare settings and for outbreak-associated infections, but inactivation efficacies of these products have not been determined against (re-)emerging viruses. In this study, we evaluated the virucidal activity of these WHO products in a comparative analysis. Zika virus (ZIKV), Ebola virus (EBOV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) as (re-)emerging viral pathogens and other enveloped viruses could be efficiently inactivated by both WHO formulations, implicating their use in healthcare systems and viral outbreak situations.


Files in this item

Thumbnail
Name:
Siddharta et al.pdf
Size:
605.9Kb
Format:
PDF
Description:
Open Access article
Thumbnail
Name:
SupplementaryInformation.pdf
Size:
129.9Kb
Format:
PDF
Description:
supplementary information
Thumbnail
Name:
SupplFigure1.tif
Size:
2.704Mb
Format:
TIFF image
Description:
supplemental figure S1
Thumbnail
Name:
SupplFigure2.tif
Size:
30.02Kb
Format:
TIFF image
Description:
supplemental figure S2
Thumbnail
Name:
SupplTable1.pdf
Size:
101.1Kb
Format:
PDF
Description:
supplemental table 1

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/